Results 201 to 210 of about 66,048 (291)

Clinical Features of Portal Hypertension and Their Prognostic Implications in Patients With Autoimmune Hepatitis

Alimentary Pharmacology &Therapeutics, EarlyView.
Features of clinically significant portal hypertension (CSPH) in patients with autoimmune hepatitis indicate a substantial risk for decompensation and impaired transplant‐free survival. Non‐invasive risk prediction based on liver stiffness measurement ≥ 15 kPa and/or thrombocytopenia (< 150 G/L) serves as a valuable surrogate to identify patients at ...
Lukas Burghart, Sonja Treiber, David Bauer, Emina Halilbasic, Benedikt S. Hofer, Mattias Mandorfer, Michael Gschwantler, Caroline Schwarz, Michael Trauner, Thomas Reiberger, Albert F. Stättermayer   +10 more
wiley   +1 more source

Comparison of endoscopic healing and durability between combination therapy with infliximab and azathioprine versus infliximab monotherapy in pediatric Crohn's disease. [PDF]

Sci Rep
Kim YZ, Kim ES, Kwon Y, Kim SY, Kim H, Choe YH, Kim MJ.   +6 more
europepmc   +1 more source

Patient survey in immune thrombocytopenia (ITP): Identifying unmet needs related to treatment and disease control in patients living in the United States

British Journal of Haematology, EarlyView.
Key aspects of this survey focused on treatment approach, controlling immune thrombocytopenia (ITP), health‐related quality of life (HRQOL) and patient support. Although most patients were receiving and adhering to ITP treatment, there was a lack of sustained efficacy, fuelling a need for better and more effective treatment options.
Nichola Cooper, Caroline Kruse, Sharon Deneen Morgan, Julie Laurent, Marleni Arvelo‐Saillant, Jean‐Pascal Roussy, Matias Cordoba, Imene Gouia, Lisa‐Anne Schmitt, Erin Reineke, Terry Gernsheimer   +10 more
wiley   +1 more source

Penile erosions: an atypical initial manifestation of pemphigus vulgaris. [PDF]

An Bras Dermatol
Leme HJ, Ramos J, Magarreiro-Silva A, Gouveia AI, Alves J.   +4 more
europepmc   +1 more source

Predictors of response to emergent therapies in paediatric immune thrombocytopenia

British Journal of Haematology, EarlyView.
Emergent therapies (ET), which include intravenous immunoglobulin (IVIG), corticosteroids and intravenous anti‐Rho(D) immunoglobulin, are used to treat acute episodes of bleeding in children with immune thrombocytopenia (ITP). Through comparison of clinical characteristics in paediatric patients with ITP responsive to ET versus those non‐responsive to ...
Candelaria O'Farrell, Taylor M. Luckie, Matthew J. Willis, Susan E. Kirk, Brandon R. Lucari, Michael E. Scheurer, Xiaotian Gao, Amanda B. Grimes   +7 more
wiley   +1 more source

Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors

British Journal of Pharmacology, EarlyView.
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen, Tamás Kovács, Péter Ferdinandy, Zoltán V. Varga   +3 more
wiley   +1 more source

Titanium: An Unusual Allergen With Various Presentations—A Retrospective Cohort Study

Contact Dermatitis, EarlyView.
Titanium, a rare allergen, should be tested in the suitable clinical setting, taking into consideration the anticipated rise in exposure through medical equipment, implants and recreational ‘Nickel free’ jewellery and tattoos. Titanium induced BP is an intriguing phenomenon that should be further explored, on the verge between allergology and ...
Danny Daniely, Valentina Zemser‐Werner, Roy Gilon‐Omer, Jonathan Bar, Dan Slodownik   +4 more
wiley   +1 more source

Myelodysplastic Syndrome in a Patient With Cronkhite-Canada Syndrome. [PDF]

Clin Case Rep
Shim KG, Khadarian K, Samadder J, Zhou J, Yi CA.   +4 more
europepmc   +1 more source

International survey of treatment practices for atopic dermatitis in pregnant and breastfeeding women: Physician perspectives

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and Objectives Systemic treatment of pregnant/breastfeeding atopic dermatitis (AD) patients is challenging due to limited safety data. We explored treatment practices with systemic agents, including the guideline‐recommended cyclosporine as the first systemic choice as well as emerging therapies, in this vulnerable population ...
Manuel P. Pereira, Katarina Stevanovic, Emek Kocatürk, Cathrin Meesch, Ingrid van Hofman, Prema S. Vaswani, Jonathan A. Bernstein, Dayanne Bruscky, Herberto J. Chong‐Neto, Chia‐Yu Chu, Roberta Fachini Jardim Criado, Luis Felipe Ensina, Ana M. Giménez‐Arnau, Kiran Godse, Maia Gotua, Stamatios Gregoriou, Kanokvalai Kulthanan, Charlotte G. Mortz, Natasa Teovska Mitrevska, Esen Özkaya, Prajwal Pudasaini, Mara Morelo Rocha Felix, Catalina Rincón Pérez, Claudio Alberto Salvador Parisi, Gonzalo N. Ramón, Efstratios Vakirlis, Zuotao Zhao, Lisa A. Beck, Marjolein de Bruin‐Weller, Michael Cork, Norito Katoh, Thomas Werfel, Margitta Worm, Andreas Wollenberg, Torsten Zuberbier   +34 more
wiley   +1 more source

Correlation of Antimuscarinic Acetylcholine Receptor Antibody Titers With Pemphigus Disease Activity at Baseline and Following Phase I Pulse Therapy. [PDF]

Cureus
Behera B, Palit A, Sahu S, Sahoo SS, Sethy M.   +4 more
europepmc   +1 more source